Adverum Appoints Esteemed Healthcare Executive Reed V. Tuckson, M.D., to Board of Directors

by NASDAQ Market News February 22, 2021

NASDAQ Market News
Click here to email author

FDA approves Libtayo® (cemiplimab-rwlc) monotherapy for patients with first-line advanced non-small cell lung cancer with PD-L1 expression of ≥50%

PDS Biotech and Farmacore Announce Blanver to Join Consortium to Commercialize Novel Versamune®-Based T-Cell Inducing COVID-19 Vaccine

Ads